卡姆雷利祖马布加上阿帕蒂尼布在固体瘤中的有效性和安全性:一个元分析
Ping Yu1, Xiaoyu Song1,2, Yue Li1
1Department of Pharmacy, Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Frontiers in immunology
|September 18, 2025
概括
这次元分析探讨了camrelizumab加上apatinib用于固体瘤,发现了短期疗效,但注意到了显著的局限性. 需要更多高质量的研究来证实这些关于癌症治疗有效性的发现.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 固体瘤是一个重大的全球健康挑战.
- 新型组合疗法对于改善患者的治疗结果至关重要.
- 卡姆雷利祖马布和阿帕蒂尼布是新兴药物,在癌症治疗中具有潜力.
研究的目的:
- 评估在固体瘤患者中与阿帕蒂尼布联合使用的卡梅利祖马布的疗效和安全性.
- 通过元分析方法综合现有证据.
- 为了确定与这种联合治疗相关的关键生存结果和不良事件.
主要方法:
- 使用来自PubMed,Embase,Web of Science和Cochrane图书馆数据库的数据进行了全面的元分析.
- 通过使用非随机化研究方法指数 (MINORS) 评分来评估研究的质量.
- 数据分析是使用R版本4.3.3.3中的元包进行的.
主要成果:
- 分析包括35篇与2224名患者的出版物,揭示了常见的不良事件,如贫血,腹,高血压,蛋白尿和疲劳.
- 目标响应率 (ORR) 为40.0%,疾病控制率 (DCR) 为78.0%.
- 24个月的总生存率 (OS) 为16.0%,24个月的无进展生存率 (PFS) 为6.7%.
结论:
- 卡梅利祖马布和阿帕蒂尼布的组合在治疗固体瘤方面显示出短期的疗效.
- 当前证据库的重大局限性需要谨慎.
- 需要高质量,多中心,大样本的随机对照试验来验证这些发现,并建立关于癌症治疗的最终结论.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.7K
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.7K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
